Inogen, Inc. (INGN)
NASDAQ: INGN · IEX Real-Time Price · USD
8.30
+0.19 (2.34%)
May 31, 2024, 4:00 PM EDT - Market closed

Inogen Revenue

Inogen had revenue of $321.52M in the twelve months ending March 31, 2024, down -12.87% year-over-year. Revenue in the quarter ending March 31, 2024 was $78.03M with 8.12% year-over-year growth. In the year 2023, Inogen had annual revenue of $315.66M, a decrease of -16.32%.

Revenue (ttm)
$321.52M
Revenue Growth
-12.87%
P/S Ratio
0.61
Revenue / Employee
$385,519
Employees
834
Market Cap
195.69M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023315.66M-61.58M-16.32%
Dec 31, 2022377.24M19.24M5.37%
Dec 31, 2021358.00M49.52M16.05%
Dec 31, 2020308.49M-53.46M-14.77%
Dec 31, 2019361.94M3.83M1.07%
Dec 31, 2018358.11M108.67M43.57%
Dec 31, 2017249.44M46.61M22.98%
Dec 31, 2016202.83M43.82M27.56%
Dec 31, 2015159.01M46.47M41.29%
Dec 31, 2014112.54M37.09M49.17%
Dec 31, 201375.44M26.87M55.31%
Dec 31, 201248.58M17.94M58.57%
Dec 31, 201130.63M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
NeuroPace 69.07M
Scilex Holding Company 47.05M
Fennec Pharmaceuticals 44.95M
Zevra Therapeutics 28.01M
TriSalus Life Sciences 21.98M
Delcath Systems 4.61M
INmune Bio 131.00K
Revenue Rankings